4.7 Article

TYROBP, TLR4 and ITGAM regulated macrophages polarization and immune checkpoints expression in osteosarcoma

Related references

Note: Only part of the references are listed.
Article Oncology

TRIM68, PIKFYVE, and DYNLL2: The Possible Novel Autophagy- and Immunity-Associated Gene Biomarkers for Osteosarcoma Prognosis

Jie Jiang et al.

Summary: Three genes, TRIM68, PIKFYVE, and DYNLL2, were identified as biomarkers for predicting the prognosis of osteosarcoma. The constructed prognostic model showed that patients with high risk had significantly lower survival rates than those with low risk. Additionally, the three genes were found to be significantly associated with immune cells, and their expressions were higher in osteosarcoma cells compared to control cells.

FRONTIERS IN ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

KEGG: integrating viruses and cellular organisms

Minoru Kanehisa et al.

Summary: KEGG is a curated resource integrating eighteen databases categorized into systems, genomic, chemical and health information, providing mapping tools for understanding cellular and organism-level functions from genome sequences and other molecular datasets. The network variation maps in the KEGG database show how different pathogens and environmental factors influence cellular signaling pathways.

NUCLEIC ACIDS RESEARCH (2021)

Article Cardiac & Cardiovascular Systems

Digital Inference of Immune Microenvironment Reveals Low-Risk Subtype of Early Lung Adenocarcinoma

Vadim Kurbatov et al.

ANNALS OF THORACIC SURGERY (2020)

Article Cell Biology

STAT1 and its related molecules as potential biomarkers in Mycobacterium tuberculosis infection

Xing-Hao Yi et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Article Veterinary Sciences

Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma

Sita S. Withers et al.

VETERINARY AND COMPARATIVE ONCOLOGY (2019)

Article Biochemistry & Molecular Biology

microRNA-211 regulates cell proliferation, apoptosis and migration/invasion in human osteosarcoma via targeting EZRIN

Yihua Pei et al.

CELLULAR & MOLECULAR BIOLOGY LETTERS (2019)

Article Oncology

Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcoma

Zhang Jingzhe et al.

JOURNAL OF BONE ONCOLOGY (2019)

Article Public, Environmental & Occupational Health

Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo

Xiaoqiang Liu et al.

ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE (2019)

Article Oncology

Identification of key gene modules for human osteosarcoma by co-expression analysis

Jing Zhang et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)

Review Medicine, Research & Experimental

TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings

Maryam A. Shetab Boushehri et al.

MOLECULAR PHARMACEUTICS (2018)

Article Pathology

PD-1 and PD-L1 expression in bone and soft tissue sarcomas

Alireza Torabi et al.

PATHOLOGY (2017)

Article Oncology

Evaluation of F8-TNF-α in Models of Early and Progressive Metastatic Osteosarcoma

Bernhard Robl et al.

TRANSLATIONAL ONCOLOGY (2017)

Article Biochemistry & Molecular Biology

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

Spencer C. Wei et al.

Review Immunology

Innate and adaptive immune cells in the tumor microenvironment

Thomas F. Gajewski et al.

NATURE IMMUNOLOGY (2013)